FIRS Laboratories, RSR Ltd, Parc Ty Glas, Llanishen, Cardiff, UK.
J Mol Endocrinol. 2023 Jan 24;70(3). doi: 10.1530/JME-22-0149. Print 2023 Apr 1.
Determination of the structure of the extracellular domain of human thyroid peroxidase (hTPO) by cryo-electron microscopy (cryo-EM) is described. TPO, purified to homogeneity was complexed with the hTPO monoclonal autoantibody 2G4 Fab and also with a mouse monoclonal TPO antibody 4F5 Fab (which competes with autoantibody binding to TPO). Both complexes were analysed by cryo-EM. The two structures (global resolution 3.92 and 3.4 Å for the 2G4 complex and 4F5 complex, respectively) show TPO as a monomer with four domains; the N-terminal domain, the peroxidase domain (POD), the complement control protein (CCP)-like domain and the epidermal growth factor-like domain which are all visible in the structures. The relative positions of the domains are fixed with a disulphide bond between cysteine residues Cys146 in the POD and Cys756 in the CCP domain preventing significant flexibility of the molecule. The entrance to the enzyme active site, the haem group and the calcium binding site are clearly visible on the opposite side of the TPO molecule from the 2G4 and 4F5 binding sites. Extensive interactions are seen between TPO and the two antibodies which both bind to distinct epitopes on the POD domain, including some residues in the immunodominant region B mainly via different residues. However, the epitopes of the two antibodies contain three shared TPO residues. This is the first high-resolution structure of TPO to be reported and it should help guide the development of new inhibitors of TPO enzyme activity for therapeutic applications.
本文描述了通过冷冻电镜(cryo-EM)确定人甲状腺过氧化物酶(hTPO)的细胞外结构域的结构。TPO 被纯化至均一性后与 hTPO 单克隆自身抗体 2G4 Fab 以及与小鼠单克隆 TPO 抗体 4F5 Fab 复合(后者与 TPO 的自身抗体竞争结合)。对这两种复合物均进行了 cryo-EM 分析。两个结构(2G4 复合物和 4F5 复合物的全局分辨率分别为 3.92 和 3.4 Å)显示 TPO 为单体,具有四个结构域;N 端结构域、过氧化物酶结构域(POD)、补体控制蛋白(CCP)样结构域和表皮生长因子样结构域在结构中均可见。通过 POD 中半胱氨酸残基 Cys146 和 CCP 结构域中半胱氨酸残基 Cys756 之间的二硫键固定了各结构域的相对位置,从而防止了分子的显著灵活性。酶活性位点的入口、血红素基团和钙结合位点在 TPO 分子的与 2G4 和 4F5 结合位点相对的一侧清晰可见。TPO 与两种抗体之间存在广泛的相互作用,这两种抗体均结合 POD 结构域上的不同表位,包括免疫显性区域 B 中的一些残基,主要通过不同的残基。然而,两种抗体的表位包含三个共享的 TPO 残基。这是 TPO 的第一个高分辨率结构,它应该有助于指导针对 TPO 酶活性的新型抑制剂的开发,用于治疗应用。